エピソード

  • Health Plan Best Practices in Psoriasis: Overcoming Access Barriers to Advanced Treatments
    2026/08/05
    This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/psoriasis-best-practices/. The psoriasis treatment landscape is rapidly evolving. Although treatment guidelines are routinely updated, ongoing innovation and the introduction of new therapies frequently render even the most current guidelines incomplete. During this podcast, managed care decision makers will expand their knowledge and learn about the importance of early intervention, prevention, and treatment of associated comorbidities, promotion of healthy lifestyle changes, and implementation of personalized treatment plans.
    続きを読む 一部表示
    1 時間 6 分
  • Myasthenia Gravis (MG): A Managed Care Guide for Emerging Evidence-Based Management Strategies
    2026/07/01
    This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/mg-management. Managed care professionals face unique challenges in optimizing outcomes for patients with MG, a rare, chronic autoimmune neuromuscular disorder characterized by fluctuating muscle weakness and fatigue. The increasing prevalence and complexity of MG, combined with rapid advances in targeted therapies, require updated knowledge and strategic approaches to coverage, management, and equitable access.
    続きを読む 一部表示
    45 分
  • Preventing Blindness: The Payer's Role in Advancing Retinal Care
    2026/07/01
    This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://managedcareeye.com/preventing-blindness. This podcast will highlight challenges across the patient journey—including access to care, benefit design, and coverage decision-making—and their impact on timely diagnosis and treatment. The expert faculty will share payer perspectives on current coverage policies, care coordination, and system-level opportunities to support earlier intervention and evidence-based care. The program will also spotlight best practice strategies successfully implemented by payers to streamline policies, reduce barriers to care, and improve patient outcomes, offering actionable insights for managed care leaders seeking to optimize eye health management and prevent avoidable blindness.
    続きを読む 一部表示
    30 分
  • Bridging the Gaps: Improving Access and Timely Diagnosis for Retinal Diseases
    2026/06/01
    This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcareeye.com/bridging-the-gaps/. This podcast will examine how payer policies shape the real world management of diabetic retinopathy (DR), diabetic macular edema (DME), and age related macular degeneration (AMD), highlighting health care provider insights on the systemic challenges that affect patient access, treatment consistency, and outcomes. Discussion will center on coverage related barriers across the patient journey, including prior authorization requirements, reimbursement constraints, and care coordination gaps that can delay or disrupt sight saving therapies. The expert faculty will outline where current prevention and treatment strategies fall short from the provider perspective and illustrate opportunities for payers to better align policies with clinical needs—ultimately strengthening care delivery, improving decision making at the point of service, and advancing system level approaches to prevent avoidable vision loss.
    続きを読む 一部表示
    35 分
  • Aligning Policy with Practice: What Providers Need from Payers in Retinal Disease Management
    2026/06/01
    This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcareeye.com/aligning-policy-with-practice/. Within the space of just a few years, several new retinal treatments have been approved promising increased durability and better patient outcomes. These conditions can significantly impact vision and quality of life for patients. This webcast will explore how clinical realities intersect with coverage policies in the management of diabetic retinopathy (DR), diabetic macular edema (DME), and age related macular degeneration (AMD). This session will highlight current practice patterns, gaps in care, and the unmet needs providers face when navigating treatment decisions for patients at risk of vision loss. Our experts will share candid perspectives on where payer policies support—or hinder—optimal outcomes, and outline practical, evidence aligned strategies payers can adopt to better enable timely, effective care. Attendees will gain a clearer understanding of the shared challenges across stakeholders and learn how collaborative best practices can improve patient outcomes in both DR/DME and AMD.
    続きを読む 一部表示
    29 分
  • Payer/Provider Collaboration to Meet Best Practice Standards in Asthma Management - Special CareTeamTalk Edition
    2026/06/01
    This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/asthma-management-best-practices/. Asthma remains a major public health issue in the US, with many patients still uncontrolled despite available treatments and evidence-based guidelines. This leads to preventable ER visits, hospitalizations, and significant costs—over $80 billion annually. The NCQA has updated HEDIS® for 2026 to include a new measure, Follow-Up After Acute and Urgent Care Visits for Asthma (AAF-E), which tracks if patients ages 5–64 receive an outpatient follow-up within 30 days after an asthma-related urgent or emergency visit. This educational activity is designed to increase awareness of the new HEDIS measure to improve outcomes of patients being treated for asthma for both managed care professionals and primary care providers.
    続きを読む 一部表示
    1 時間 2 分
  • PayerTalkCE® Presents: Navigating the Complexities of Hypertrophic Cardiomyopathy
    2026/04/01
    This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/hypertrophic-cardiomyopathy-payertalkce/. Through a multidisciplinary discussion format, the podcast will address critical gaps in payer understanding of hypertrophic cardiomyopathy (HCM), including guideline interpretation, coverage implications, emerging pharmacologic options such as cardiac myosin inhibitors, and the importance of shared decision‑making to support individualized, high‑quality care. Using real‑world HCM case scenarios, the faculty will explore strategies to optimize benefit design, prior authorization, and access pathways to improve clinical and economic outcomes across health systems. Learners will receive targeted, practical insights that can help payers implement evidence‑based policies that enhance appropriate, timely treatment for patients with HCM.
    続きを読む 一部表示
    46 分
  • PayerTalkCE® Presents: Emerging HER2-targeting Therapies for the Management of GI Cancers
    2025/06/18
    In this episode of PayerTalkCE®, we will delve into the innovations around HER2-targeting therapies and their role in the treatment of select gastrointestinal cancers. Topics will include the latest evidence and the integration of new treatments into health care systems, insurance coverage, reimbursement challenges, and the overall impact on health care policy. This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/gi-cancer-management/.
    続きを読む 一部表示
    31 分